All session are in Eastern Time (E.T)
*Program is subject to change.
Thursday, October 2, 2025
| 5:00 PM - 9:00 PM |
Pre-Conference Dinner
|
| 5:00 PM - 9:00 PM |
Pre-Conference Dinner
|
| 5:00 PM - 9:00 PM |
Pre-Conference Dinner
|
Friday, October 3, 2025
|
WELCOME
|
|
| 7:00 AM - 8:00 AM |
Registration and Breakfast
|
| 8:00 AM - 8:10 AM |
Opening Remarks
|
|
Rare Mutations Section
|
|
| 8:10 AM - 8:15 AM |
HER2 Case Presentation Presented by: Dr. Unice Chang |
| 8:15 AM - 8:40 AM | What About HER? HER2-Targeted Treatments in Lung Cancer |
| 8:40 AM - 8:45 AM |
Atypical EGFR Mutation Case Presentation
|
| 8:45 AM - 9:10 AM | Not Your Typical EGFR: Advancements in the Management of Atypical EGFR Mutations in Lung Cancer |
| 9:10 AM - 9:40 AM | KRASh Course on KRAS Non-G12C Mutated Lung Cancer |
| 9:40 AM - 10:00 AM |
Managing the Mutants: Panel Discussion and Questions for Atypical EGFR, HER2, and KRAS non-G12C
|
| 10:00 AM - 10:30 AM |
Morning Networking Break
|
|
Rare Fusions Section
|
|
| 10:30 AM - 10:35 AM |
ROS1 Case Presentation
|
| 10:35 AM - 11:00 AM |
A ROSy Outlook? Advancements in the Treatment of ROS1 Mutated Lung Cancers
|
| 11:00 AM - 11:10 AM |
NRG1 Discovery and Case Presentation
|
| 11:10 AM - 11:30 AM | Feeling NRGetic: Mechanisms and Advancements in the Treatment of NRG1 Mutated Lung Cancers |
| 11:30 AM - 11:35 AM |
NTRK Case Presentation
|
| 11:35 AM - 12:00 PM | NTRK: The Next Generation |
| 12:00 PM - 12:20 PM |
The Future of Fusions: Panel Discussion and Questions for NRG1 and NTRK
|
| 12:20 PM - 1:20 PM |
Networking Lunch
|
|
Looking to the Future
|
|
| 1:20 PM - 1:35 PM | SMARC for Dummies: Pathobiology of SMARCA4 |
| 1:35 PM - 1:50 PM | What the SMARC? Natural History and Clinical Impact |
| 1:50 PM - 1:55 PM |
MTAP Case Presentation
|
| 1:55 PM - 2:05 PM | An Intricate TAP Dance: The Pathobiology of MTAP Deleted Lung Cancers |
| 2:05 PM - 2:30 PM | Treatments on TAP: Management of MTAP Deleted Lung Cancers |
| 2:30 PM - 2:45 PM |
Future targets: Panel Discussion and Questions for SMARCA4 and MTAP
|
| 2:45 PM - 3:15 PM |
Afternoon Networking Break
|
|
Testing and Reporting
|
|
| 3:15 PM - 3:35 PM | Making a Splash: The Role of Liquid Biopsy in Detecting Actionable Mutations |
| 3:35 PM - 3:55 PM | Uncharted Waters: New Directions in Liquid Biopsy |
| 3:55 PM - 4:15 PM | Oceans of Data: What should be reported on NGS reports? |
| 4:15 PM - 4:30 PM |
It’s in our DNA: Panel Discussion and Questions for Liquid Biopsy and NGS Testing
|
| 4:30 PM - 4:45 PM |
Closing Remarks
|
|
WELCOME
|
|
| 7:00 AM - 8:00 AM |
Registration and Breakfast
|
| 8:00 AM - 8:10 AM |
Opening Remarks
|
|
Rare Mutations Section
|
|
| 8:10 AM - 8:15 AM |
HER2 Case Presentation Presented by: Dr. Unice Chang |
| 8:15 AM - 8:40 AM | What About HER? HER2-Targeted Treatments in Lung Cancer |
| 8:40 AM - 8:45 AM |
Atypical EGFR Mutation Case Presentation
|
| 8:45 AM - 9:10 AM | Not Your Typical EGFR: Advancements in the Management of Atypical EGFR Mutations in Lung Cancer |
| 9:10 AM - 9:40 AM | KRASh Course on KRAS Non-G12C Mutated Lung Cancer |
| 9:40 AM - 10:00 AM |
Managing the Mutants: Panel Discussion and Questions for Atypical EGFR, HER2, and KRAS non-G12C
|
| 10:00 AM - 10:30 AM |
Morning Networking Break
|
|
Rare Fusions Section
|
|
| 10:30 AM - 10:35 AM |
ROS1 Case Presentation
|
| 10:35 AM - 11:00 AM |
A ROSy Outlook? Advancements in the Treatment of ROS1 Mutated Lung Cancers
|
| 11:00 AM - 11:10 AM |
NRG1 Discovery and Case Presentation
|
| 11:10 AM - 11:30 AM | Feeling NRGetic: Mechanisms and Advancements in the Treatment of NRG1 Mutated Lung Cancers |
| 11:30 AM - 11:35 AM |
NTRK Case Presentation
|
| 11:35 AM - 12:00 PM | NTRK: The Next Generation |
| 12:00 PM - 12:20 PM |
The Future of Fusions: Panel Discussion and Questions for NRG1 and NTRK
|
| 12:20 PM - 1:20 PM |
Networking Lunch
|
|
Looking to the Future
|
|
| 1:20 PM - 1:35 PM | SMARC for Dummies: Pathobiology of SMARCA4 |
| 1:35 PM - 1:50 PM | What the SMARC? Natural History and Clinical Impact |
| 1:50 PM - 1:55 PM |
MTAP Case Presentation
|
| 1:55 PM - 2:05 PM | An Intricate TAP Dance: The Pathobiology of MTAP Deleted Lung Cancers |
| 2:05 PM - 2:30 PM | Treatments on TAP: Management of MTAP Deleted Lung Cancers |
| 2:30 PM - 2:45 PM |
Future targets: Panel Discussion and Questions for SMARCA4 and MTAP
|
| 2:45 PM - 3:15 PM |
Afternoon Networking Break
|
|
Testing and Reporting
|
|
| 3:15 PM - 3:35 PM | Making a Splash: The Role of Liquid Biopsy in Detecting Actionable Mutations |
| 3:35 PM - 3:55 PM | Uncharted Waters: New Directions in Liquid Biopsy |
| 3:55 PM - 4:15 PM | Oceans of Data: What should be reported on NGS reports? |
| 4:15 PM - 4:30 PM |
It’s in our DNA: Panel Discussion and Questions for Liquid Biopsy and NGS Testing
|
| 4:30 PM - 4:45 PM |
Closing Remarks
|
|
WELCOME
|
|
| 7:00 AM - 8:00 AM |
Registration and Breakfast
|
| 8:00 AM - 8:10 AM |
Opening Remarks
|
|
Rare Mutations Section
|
|
| 8:10 AM - 8:15 AM |
HER2 Case Presentation Presented by: Dr. Unice Chang |
| 8:15 AM - 8:40 AM | What About HER? HER2-Targeted Treatments in Lung Cancer |
| 8:40 AM - 8:45 AM |
Atypical EGFR Mutation Case Presentation
|
| 8:45 AM - 9:10 AM | Not Your Typical EGFR: Advancements in the Management of Atypical EGFR Mutations in Lung Cancer |
| 9:10 AM - 9:40 AM | KRASh Course on KRAS Non-G12C Mutated Lung Cancer |
| 9:40 AM - 10:00 AM |
Managing the Mutants: Panel Discussion and Questions for Atypical EGFR, HER2, and KRAS non-G12C
|
| 10:00 AM - 10:30 AM |
Morning Networking Break
|
|
Rare Fusions Section
|
|
| 10:30 AM - 10:35 AM |
ROS1 Case Presentation
|
| 10:35 AM - 11:00 AM |
A ROSy Outlook? Advancements in the Treatment of ROS1 Mutated Lung Cancers
|
| 11:00 AM - 11:10 AM |
NRG1 Discovery and Case Presentation
|
| 11:10 AM - 11:30 AM | Feeling NRGetic: Mechanisms and Advancements in the Treatment of NRG1 Mutated Lung Cancers |
| 11:30 AM - 11:35 AM |
NTRK Case Presentation
|
| 11:35 AM - 12:00 PM | NTRK: The Next Generation |
| 12:00 PM - 12:20 PM |
The Future of Fusions: Panel Discussion and Questions for NRG1 and NTRK
|
| 12:20 PM - 1:20 PM |
Networking Lunch
|
|
Looking to the Future
|
|
| 1:20 PM - 1:35 PM | SMARC for Dummies: Pathobiology of SMARCA4 |
| 1:35 PM - 1:50 PM | What the SMARC? Natural History and Clinical Impact |
| 1:50 PM - 1:55 PM |
MTAP Case Presentation
|
| 1:55 PM - 2:05 PM | An Intricate TAP Dance: The Pathobiology of MTAP Deleted Lung Cancers |
| 2:05 PM - 2:30 PM | Treatments on TAP: Management of MTAP Deleted Lung Cancers |
| 2:30 PM - 2:45 PM |
Future targets: Panel Discussion and Questions for SMARCA4 and MTAP
|
| 2:45 PM - 3:15 PM |
Afternoon Networking Break
|
|
Testing and Reporting
|
|
| 3:15 PM - 3:35 PM | Making a Splash: The Role of Liquid Biopsy in Detecting Actionable Mutations |
| 3:35 PM - 3:55 PM | Uncharted Waters: New Directions in Liquid Biopsy |
| 3:55 PM - 4:15 PM | Oceans of Data: What should be reported on NGS reports? |
| 4:15 PM - 4:30 PM |
It’s in our DNA: Panel Discussion and Questions for Liquid Biopsy and NGS Testing
|
| 4:30 PM - 4:45 PM |
Closing Remarks
|
